Illumina
ILMN
$5.72 (-3.42%)
1D
1W
3M
1Y
5Y
ALL
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 4 days ago • ILMN
ILMN Stock Jumps 98.7% in a Year: What's Powering the Surge?
Zacks Investment Research • 5 days ago • ILMN
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026
PRNewsWire • 10 days ago • ILMN
Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
PRNewsWire • 10 days ago • ILMN
Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
Zacks Investment Research • 11 days ago • ILMN
Here's Why Illumina (ILMN) is a Strong Momentum Stock
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.